10 Medical Breakthroughs to Watch for in the Next 10 Years. (2006, March 29). Daily Herald (Arlington Heights, IL), p. 1.
BBI Snaps Up Second Scottish Biotech Company. (2006, July 21). Western Mail (Cardiff, Wales), p. 32.
Bhandari, M., Garg, R., Glassman, R., Ma, P. C., & Zemmel, R. W. (1999). A Genetic Revolution in Health Care. 58.
Breheny, M. (2007). Genetic Attribution for Schizophrenia, Depression, and Skin Cancer: Impact on Social Distance. New Zealand Journal of Psychology, 36(3), 154+.
Celera Developing Cancer Treatment; Technology Neutralizes Genes. (2008, April 15). The Washington Times, p. C10.
Dealing with Doubt; Uncertainty over a Child’s Parentage Can Cause Stress but the Solution Is Close at Hand, Says Laura Davis. (2004). 10.
Dyson, A. & Harris, J. (Eds.). (1994). Ethics and Biotechnology. New York: Routledge.
Embryo Testing for Breast Cancer; IVF Screening ‘In Months’ on Diseases Which Wouldn’t Develop for 40 Years. (2005, April 26). The Daily Mail (London, England), p. 6.
Foster, G. (2002, April 25). Punters Pile in on LSE Merger Talks. The Daily Mail (London, England), p. 68.
An Industry at the Heart of Our Lives. (2004). 24.
Johns, M. (2001, May). Frontiers in Diagnostics. World and I, 16, 132.
Lantz, R. C., Lynch, B. J., Boitano, S., Poplin, G. S., Littau, S., Tsaprailis, G., et al. (2007). Pulmonary Biomarkers Based on Alterations in Protein Expression after Exposure to Arsenic. Environmental Health Perspectives, 115(4), 586+.
Mehlman, M. J., & Botkin, J. R. (1998). The Challenge to Equality The Challenge to Equality. Washington, DC: Georgetown University Press.
Miller, H. I., & Henderson, D. R. (2007). The FDA’s Risky Risk-Aversion. Policy Review, (145), 3+.
Mossialos, E., Mrazek, M., & Walley, T. (Eds.). (2004). Regulating Pharmaceuticals in Europe: Striving for Efficiency, Equity, and Quality. Maidenhead, England: Open University Press.
Overboe, J. (2007). Disability and Genetics: Affirming the Bare Life . The Canadian Review of Sociology and Anthropology, 44(2), 219+.
Pearson, I., & Neild, I. (2006, March/April). A Timeline for Technology: To the Year 2030 and beyond; What’s Ahead in Technology, and What Will It Mean? This New Timeline Offers a Glimpse of Likely Developments-And of How They May Change Our Lives. The Futurist, 40, 31+.
Peston, R. (2002, January 14). If We Must Give Honours to Business People, Let’s Have a Quota and Sell Them to the Highest Bidder. New Statesman, 131, 20.
Petersen, A., & Bunton, R. (2002). The New Genetics and the Public’s Health. London: Routledge.
Rados, C. (2005, November/December). Genomics and Medical Devices: A New Paradigm for Health Care. FDA Consumer, 39,.
Region’s World First MRSA Test. (2008, March 21). The Birmingham Post (England), p. 5.
Sex Selection: Who’s Doing It and How It’s Done. (2007, July 12). The Birmingham Post (England), p. 3.
Silverman, P. H. (2005). Commerce and Genetic Diagnostics. The Hastings Center Report, 25(3), 15+.
Silverstein, S. C. (2001, Fall). From Genomics and Informatics to Medical Practice. Issues in Science and Technology, 18, 37.
Stoller, D. (2007). Prenatal Genetic Screening: The Enigma of Selective Abortion. Journal of Law and Health, 12(1), 121-140.
Why Doctors Are Terrified by These New Diy Test Kits. (1996, May 28). The Daily Mail (London, England), p. 41.
Wolbring, G. (2003). Disability Rights Approach toward Bioethics?. Journal of Disability Policy Studies, 14(3), 174+.